Trials / Conditions / Pancreatic Carcinoma Metastatic
Pancreatic Carcinoma Metastatic
5 registered clinical trials studyying Pancreatic Carcinoma Metastatic.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) NCT05642962 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Terminated | Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors NCT04659603 | Sanofi | Phase 2 |
| Completed | Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis NCT03152487 | AdventHealth | N/A |
| Completed | Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma NCT02391662 | Asociación de Oncología Médica del Hospital de Cruces | Phase 2 |
| Completed | Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer NCT01547260 | Maria Liljefors | Phase 1 / Phase 2 |